TY  - GEN 
AU  - Quiñonero Muñoz, Francisco José
AU  - Mesas Hernández, Cristina
AU  - Muñoz Gámez, José Antonio
AU  - Jiménez Luna, Cristina
AU  - Perazzoli, Gloria
AU  - Prados Salazar, José Carlos
AU  - Melguizo Alonso, Consolación
AU  - Ortiz Quesada, Raúl
PY  - 2022
UR  - https://hdl.handle.net/10481/77618
AB  - Pancreatic cancer (PC) is one of the tumors with the lowest survival rates due to the poor efficacy of the
treatments currently used. Gemcitabine (GMZ), one of the chemotherapeutic agents employed when the tumor is
unresectable, frequently fails due...
LA  - eng
PB  - Elsevier
KW  - PARP1
KW  - Pancreatic cancer
KW  - Olaparib
KW  - Gemcitabine
KW  - Drug resistance
TI  - PARP1 inhibition by Olaparib reduces the lethality of pancreatic cancer cells and increases their sensitivity to Gemcitabine
DO  - 10.1016/j.biopha.2022.113669
ER  -